IDEAYA Biosciences (IDYA) Income from Continuing Operations: 2020-2025
Historic Income from Continuing Operations for IDEAYA Biosciences (IDYA) over the last 4 years, with Sep 2025 value amounting to $108.5 million.
- IDEAYA Biosciences' Income from Continuing Operations rose 262.13% to $108.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$167.5 million, marking a year-over-year increase of 25.47%. This contributed to the annual value of -$327.0 million for FY2024, which is 143.23% down from last year.
- As of Q3 2025, IDEAYA Biosciences' Income from Continuing Operations stood at $108.5 million, which was up 175.24% from -$144.1 million recorded in Q4 2024.
- IDEAYA Biosciences' 5-year Income from Continuing Operations high stood at $108.5 million for Q3 2025, and its period low was -$144.1 million during Q4 2024.
- Its 3-year average for Income from Continuing Operations is -$39.2 million, with a median of -$41.9 million in 2023.
- Its Income from Continuing Operations has fluctuated over the past 5 years, first crashed by 5,179.70% in 2023, then skyrocketed by 262.13% in 2025.
- Over the past 5 years, IDEAYA Biosciences' Income from Continuing Operations (Quarterly) stood at -$18.4 million in 2021, then tumbled by 43.95% to -$26.4 million in 2022, then tumbled by 58.52% to -$41.9 million in 2023, then crashed by 243.87% to -$144.1 million in 2024, then skyrocketed by 262.13% to $108.5 million in 2025.
- Its Income from Continuing Operations was $108.5 million in Q3 2025, compared to -$144.1 million in Q4 2024 and -$66.9 million in Q3 2024.